Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, announced on Tuesday that it is constructing a new pharmaceutical manufacturing facility in North Carolina's Research Triangle Park.

The company said it will invest over USD470m in this state-of-the-art facility that will produce parenteral (or injectable) products and delivery devices. In addition, Lilly will create more than 400 jobs in highly skilled positions such as scientists, engineers, quality professionals and manufacturing operations.

"Life science companies like Lilly continue to choose North Carolina," said Roy Cooper, Governor of North Carolina. "Our exceptional workforce draws global companies as we continue to grow North Carolina into a worldwide hub for the biotechnology industry."